NEW_VeronaCorp_Logo_Inline_With_RGB - for notfied.jpg
Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024
May 02, 2024 02:00 ET | Verona Pharma plc
Verona Pharma plc to present additional analyses of positive Phase 3 ENHANCE studies in COPD at ATS 2024.
argenx_logo_default.png
argenx to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024
May 02, 2024 01:00 ET | argenx SE
May 2, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today...
G1_Logo_2022_Reg.png
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 01, 2024 17:50 ET | G1 Therapeutics
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PENNANT_LOGO.png
Pennant Acquires Senior Living Community in Idaho
May 01, 2024 17:32 ET | Pennant Group, Inc.
EAGLE, Idaho, May 01, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living...
Zentalis logo.png
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 01, 2024 17:30 ET | ZENTALIS PHARMACEUTICALS
NEW YORK and SAN DIEGO, May 01, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically...
PENNANT_LOGO.png
Pennant Acquires Utah Home Health and Hospice Provider
May 01, 2024 17:09 ET | Pennant Group, Inc.
EAGLE, Idaho, May 01, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living...
Unknown.png
TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public Offering
May 01, 2024 17:07 ET | TFF Pharmaceuticals, Inc.
FORT WORTH, Texas, May 01, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the “Company” or “TFF Pharmaceuticals”), a clinical-stage biopharmaceutical company focused on developing...
Advantage Logo.jpg
Advantage Solutions takes next step to simplify portfolio by selling digital marketing agency Adlucent to BarkleyOKRP
May 01, 2024 17:00 ET | Advantage Solutions, Inc.
ST. LOUIS, May 01, 2024 (GLOBE NEWSWIRE) -- Advantage Solutions Inc. (NASDAQ: ADV), a leading provider of sales and marketing services to consumer goods manufacturers and retailers, today announced...
RGC Resources, Inc. Reports Second Quarter Earnings
May 01, 2024 17:00 ET | RGC Resources Inc.
ROANOKE, Va., May 01, 2024 (GLOBE NEWSWIRE) -- RGC Resources, Inc. (NASDAQ: RGCO) announced consolidated Company earnings of $6,443,390, or $0.63 per share, for the second quarter ended March 31,...
Embecta_Logo.jpg
embecta to Participate in Investor Events
May 01, 2024 17:00 ET | Embecta Corp.
PARSIPPANY, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced that...